With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.
Dubai to launch drone delivery services at parks, beaches
UAE, India ink defence, energy partnerships as Sheikh Mohamed meets Modi
UAE issues advisory over Danalac infant formula
H.H. Sheikh Mohammed opens DEWA's 'largest, smartest net-zero energy' HQ
UAE to restore Umayyad Mosque in Syria's Damascus
WATCH: Dubai driver caught for reckless stunts on high-speed highway
UAE brokers new round of Russia-Ukraine prisoner exchange
H.H. Sheikh Khaled briefed on West-East oil pipeline project
Dubai's RTA impounds over 9,000 cars in 2025 for illegal parking
UAE condemns attack on Indian-flagged ship off Oman coast
UAE, UK ministers discuss regional stability, bilateral ties
H.H. Sheikh Hamdan reviews operations, developments at Jebel Ali Port
Drugs hidden inside passenger’s body seized at Abu Dhabi Airport
UAE President, Montenegro PM discuss stronger bilateral cooperation
Fujairah says pipeline work triggered fire in petroleum industries area
Yas Island announced as location for Sphere Abu Dhabi project
Warning issued on dangers of sudden road stops after 1 dead, 19 injured
UAE says reports of Israeli PM Netanyahu's visit 'entirely unfounded'
UAE launches platform to help Emiratis choose 'right academic, career paths'
Dubai Customs foils attempt to smuggle endangered bears through airport
